(S)-Lansoprazole
Product Sizes
100 mg
£ POA
HY-13662C-100MG
10 mg
£ POA
HY-13662C-10MG
5 mg
£ POA
HY-13662C-5MG
1 mg
£ POA
HY-13662C-1MG
50 mg
£ POA
HY-13662C-50MG
10mM/1mL
£ POA
HY-13662C-10MM
About this Product
- SKU:
- HY-13662C
- Additional Names:
- Levolansoprazole
- CAS Number:
- 138530-95-7
- Extra Details:
- (S)-Lansoprazole (Levolansoprazole) is an isoform of Lansoprazole (HY-13662); which is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].
- Molecular Weight:
- 369.36
- Purity:
- 99.17
- References:
- [1]Kokufu, T., et al., Effects of lansoprazole on pharmacokinetics and metabolism of theophylline. Eur J Clin Pharmacol, 1995. 48(5): p. 391-5.|[2]Huarui Zhang, et al. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1322-1330.|[3]Rupinder K Sodhi, et al. Defensive effect of lansoprazole in dementia of AD type in mice exposed to streptozotocin and cholesterol enriched diet. PLoS One. 2013 Jul 31;8(7):e70487.|[4]Jun Matsukawa, et al. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. Biochem Pharmacol. 2011 May 1;81(9):1145-51.|[5]Erdinc Naseri, et al. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries. Eur J Pharmacol. 2006 Feb 15;531(1-3):226-31.
- Research Area:
- Inflammation/Immunology
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C (Powder; protect from light)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Anti-infection;Membrane Transporter/Ion Channel;Metabolic Enzyme/Protease
